öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º´ÞÑô
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º4

ËùÊôԺУ£ºÄÏ·½Ò½¿Æ´óѧ
ËùÊôԺϵ£º¹ã¶«Ê¡ÈËÃñÒ½Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º Ç¿Ö±ÐÔ¼¹ÖùÑײ¡Àí¹Ç»¯µÄ»úÀíÑо¿£¬ÒÔ¼°¼Ì·¢ÐÔ¹ÇÖÊÊèËɵÄÕïÁÆÒÔ¼°»úÀíÑо¿
Ñо¿ÁìÓò£º Ç¿Ö±ÐÔ¼¹ÖùÑײ¡Àí¹Ç»¯µÄ»úÀíÑо¿£¬ÒÔ¼°¼Ì·¢ÐÔ¹ÇÖÊÊèËɵÄÕïÁÆÒÔ¼°»úÀíÑо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£º**@139.com


¸öÈ˼òÊö :
Ò». Ç¿Ö±ÐÔ¼¹ÖùÑײ¡Àí¹Ç»¯µÄ»úÀíÑо¿1.Ñо¿TNF-¦ÁÞ׿¹¼Á¼°µ¤²ÎÓÐЧ³É·Ö¶ÔWnt¦Â-cateninºÍTGF-¦ÂBMPÐźÅͨ ·µÄÓ°Ï죬ÕâЩµ÷½Ú×÷ÓöÔÇ¿Ö±ÐÔ¼¹ÖùÑ×ÖÐÖá¹Ø½Ú³öÏÖ¹Ç׸£¬¼´ÏËά»¯¼°¹ÇÐÔÇ¿Ö±µÄ¹Ø¼ü×÷Óá£TNF-¦Á ÒÖÖƼÁÒÀºÍµ¤²Î·ÓËáÑÎ×¢Éä¼ÁÁªºÏÓ¦Óã¬ÔÚÁÙ´²ÉÏÖÎÁÆÇ¿Ö±ÐÔ¼¹ÖùÑ×ÖÐÖá¹Ø½Ú¹Ç׸£¬¼´ÏËά»¯¼°¹ÇÐÔÇ¿Ö±£¬ÔÚÒ»¶¨³Ì¶ÈÉϽâ¾öÁÙ´²Ç¿Ö±ÐÔ¼¹ÖùÑ×ÖÎÁƵÄÄÑÌ⣬Èô³É¹¦Íƹ㣬ÔòÔÚÇ¿Ö±ÐÔ¼¹ÖùÑ×µÄÖÎÁÆѧºÍÁÙ´²Ò½Ñ§ÉϿɲúÉú²»¿É¹ÀÁ¿µÄÉç»áЧÒæ¡£2.TNF-aÒÖÖƼÁÊÇSpAÖÎÁƵÄÀï³Ì±®£¬µ«Ò©ÎïµÄ³¤ÆÚʹÓöԻ¼Õß¹Ç׸ÐγɵÄÓ°ÏìÈÔδÓж¨ÂÛ¡£Í¨¹ý¹Û²ìSpA³¤ÆÚʹÓÃTNF-aÒÖÖƼÁÖÎÁƺóÁÙ´²ÆÀ¹À¡¢·ÅÉäѧºÍºË´Å¹²ÕñµÄ¸Ä±ä£¬Ì½ÌÖTNF-aÒÖÖƼÁ¶Ô¹Ç׸ÐγɵÄ×÷Óᣲ¢ÇÒ£¬½øÒ»²½¹Ø×¢ÉúÎïÖƼÁ¼õÍ£Ò©µÄÖÎÁÆ·½°¸£¬Ò»·½Ãæ¼õÉÙʹÓÃÉúÎïÖƼÁµ¼ÖµÄÒҸΡ¢½áºËµÈ¸ÐȾ·çÏյķ¢Éú£¬ÁíÒ»·½Ã棬°ïÖúÖÚ¶àÄêÇáµÄSpA»¼Õß¼õÇá¼²²¡ÖÎÁƵľ­¼Ã¸ºµ£¡£ ¶þ£®¼Ì·¢ÐÔ¹ÇÖÊÊèËɵÄÕïÁÆÒÔ¼°»úÀíÑо¿1.´ÓϵͳÐÔºì°ßÀÇ´¯£¨SLE£©µÄÌÇƤÖʼ¤ËØÓÕ·¢¹ÇÖÊÊèËÉ£¨GIOP£©¶¯ÎïʵÑéÒÔ¼°È˹Ǵúл±êÖ¾Îï¡¢ÔÚÌå¹Ç×éÖ¯ÐÎ̬¼ÆÁ¿Ñ§¡¢¹ÇÃܶÈ¡¢ºË´Å¹²Õñ³ÉÏñµÈ¶à¸ö·½ÃæÑо¿½áµÞ×éÖ¯²¡ÒÔ¼°ÌÇƤÖʼ¤ËØÓÕ·¢¹ÇÖÊÊèËÉÖ¢µÄ·¢²¡»úÀí£»²ÉÓÃSLEµÄGIOP¶¯ÎïÄ£ÐÍÑо¿½áµÞ×éÖ¯²¡»òÌÇƤÖʼ¤ËØÓÕ·¢¹ÇÖÊÊèËÉÖ¢ÔÚ¹úÄÚÄËÖÁ¹úÍâÊôÁìÏȵØ룬¿ÉΪÒÔºóµÄÁÙ´²ÓÅ»¯ÖÎÁÆÌṩʵÑéÊÒÒÀ¾Ý¡£2. Ìá³öÓÃÖÐÒ©µ¤²ÎË®ÈÜÐÔÓÐЧ²¿Î»Èº£¨µ¤²Î¶à·Ó£©ÖÎÁÆSLE»¼Õß¼¤ËØÓÕµ¼¼Ì·¢¹ÇÖÊÊèËɵĹ¹Ë¼£¬¾ßÓÐÃ÷ÏԵĴ´ÐÂÐÔ£¬»ñµÃ¹ã¶«Ê¡¿Æ¼¼ÌüµÄ¿ÆÑÐ×ÊÖú¡£

¿ÆÑй¤×÷ :
£¨1£©Cui Y,Zheng J,Zhang X,Zeng H,Luo R.Evaluation of treatments for sacroiliitis in spondyloarthropathy using the Spondyloarthritis Research Consortium Canada scoring system[J]. Arthritis Res Ther,2016,18(1):38.£¨2£© Liu Y,Cui Y,Chen Y,Gao X,Su Y,Cui L.Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats[J]. Clin Interv Aging,2015,10:1245-1253.